new IV monoclonal antibody for severe systemic lupus erythematosus (SLE), Benlysta (ben-LIST-a, belimumab)

You'll hear about a new IV monoclonal antibody for severe systemic lupus erythematosus (SLE), Benlysta (ben-LIST-a, belimumab).

It's the first biologic drug for lupus.

It'll be out soon in the U.S...and is also being considered for approval in Canada.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote